FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
| Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
|---|---|---|---|---|---|
| METHOTREXATE | 52652-2001-1 | Azurity Pharmaceuticals, Inc. | NDA208400 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 0143-9367-01 | Hikma Pharmaceuticals USA Inc. | ANDA040632 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 70771-1058-5 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-022-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-025-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 70518-1398-1 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-025-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 70771-1058-0 | Zydus Lifesciences Limited | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-025-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 68382-775-05 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-017-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 52652-2001-6 | Azurity Pharmaceuticals, Inc. | NDA208400 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 0904-7141-10 | Major Pharmaceuticals | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-015-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-020-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-022-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 70518-1398-2 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-022-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 70518-1398-4 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-010-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 16729-277-03 | Accord Healthcare, Inc. | ANDA040716 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 70518-1398-5 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 70518-1398-3 | REMEDYREPACK INC. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-012-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 54436-020-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 68382-775-16 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 68382-775-60 | Zydus Pharmaceuticals USA Inc. | ANDA207812 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-015-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| METHOTREXATE | 0143-9517-01 | Hikma Pharmaceuticals USA Inc. | ANDA089342 | HUMAN PRESCRIPTION DRUG | ANDA |
| METHOTREXATE | 54436-020-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
| 1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-
